Back to search results

Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia

Abroad (travel likely)RecruitingPHASE2

Conditions

Severe Aplastic Anemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Blood and Marrow Transplant Group of Georgia, Atlanta, Georgia, United States

    Contact: Study coordinator (Melhem Solh, MD) · msolh@bmtga.com · 404-255-1930

  • Northside Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Melhem Solh, MD) · msolh@bmtga.com · 404-255-1930
    Contact: Study coordinator (Stacey Brown) · stacey.brown@northside.com · 404-851-8238
    Scott Solomon, MD (Sub-investigator)
    H. Kent Holland, MD (Sub-investigator)
    Asad Bashey, MD, PhD (Sub-investigator)
    Lawrence Morris, MD (Sub-investigator)
    Contact: Principal Investigator (Melhem Solh, MD)
Study leads

  • Melhem Solh, MD

    Principal Investigator

    Blood and Marrow Transplant Group of Georgia

View source on ClinicalTrials.gov(opens in a new tab)